本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Can-Fite Biopharma Ltd

1.04
0.0000
盤後1.01-0.0250-2.42%18:00 EDT
成交量:3.19萬
成交額:3.30萬
市值:1,374.27萬
市盈率:-0.95
高:1.05
開:1.05
低:1.02
收:1.04
資料載入中...
2019/09/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/11

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/09/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/08

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/12

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2019/07/10

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/28

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2019/06/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/14

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/06/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/06

超過5%披露

[Amend] General statement of acquisition of beneficial ownership